Levomilnacipran and Hand deformity - a phase IV clinical study of FDA data

Summary:

Hand deformity is reported as a side effect among people who take Levomilnacipran (levomilnacipran), especially for people who are female, 40-49 old, also take Azathioprine, and have Migraine.

The phase IV clinical study analyzes which people have Hand deformity when taking Levomilnacipran. It is created by eHealthMe based on reports of 117 people who have side effects when taking Levomilnacipran from the FDA, and is updated regularly.

What is Levomilnacipran?

Levomilnacipran has active ingredients of levomilnacipran. eHealthMe is studying from 118 Levomilnacipran users. Check the latest studies of Levomilnacipran.

What is Hand deformity?

Hand deformity is found to be associated with 523 drugs and 405 conditions by eHealthMe. Check the latest studies of Hand deformity.

On Jul, 08, 2026

117 people reported to have side effects when taking Levomilnacipran.
Among them, 14 people (11.97%) have Hand deformity.

Could Levomilnacipran cause Hand deformity?

Among these 14 people:

What is the gender of people who have Hand deformity when taking Levomilnacipran? *

female: 100 %
male: 0.0 %

What is the age of people who have Hand deformity when taking Levomilnacipran? *

What are other drugs people take besides Levomilnacipran? *

What are other side effects people have besides Hand deformity? *

Wound Infection: 14 people, 100.00%
Hypoaesthesia (reduced sense of touch or sensation): 14 people, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 100.00%
General Physical Health Deterioration (weak health status): 14 people, 100.00%
Glossodynia (a burning or painful sensation in the tongue): 14 people, 100.00%
Hair Loss: 14 people, 100.00%
Helicobacter Infection (helicobacter pylori (h. pylori) infects stomach): 14 people, 100.00%
Hepatic Enzyme Increased: 14 people, 100.00%
High Blood Cholesterol: 14 people, 100.00%
High Blood Pressure: 14 people, 100.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 100.00%
Psoriasis (immune-mediated disease that affects the skin): 14 people, 100.00%
Migraine (headache): 14 people, 100.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 64.29%
Arthropathy: 5 people, 35.71%

* Approximation only. Some reports may have incomplete information.

Do you take Levomilnacipran and have Hand deformity?

- Check whether Hand deformity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levomilnacipran:

Levomilnacipran (118 reports)

Hand deformity treatments and more:

Hand deformity (14,592 reports)

Browse all side effects of Levomilnacipran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hand deformity:

Hand deformity (523 drugs)

Browse all the conditions that are associated with Hand deformity:

Hand deformity (405 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levomilnacipran (the active ingredients of Levomilnacipran) and Levomilnacipran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.